J Kuriki
Overview
Explore the profile of J Kuriki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshioka K, Kobayashi M, Orito E, Watanabe K, Yano M, Sameshima Y, et al.
J Viral Hepat
. 2001 Nov;
8(6):421-9.
PMID: 11703573
Biochemical responders maintain normal alanine aminotransferase levels after interferon (IFN) therapy despite persistent presence of hepatitis C virus (HCV) RNA in their sera. There have been few reports on predictive...
2.
Yoshioka K, Yano M, Kusakabe A, Hirofuji H, Fuji A, Kuriki J, et al.
Am J Gastroenterol
. 1999 Feb;
94(1):164-8.
PMID: 9934749
Objective: We conducted a randomized controlled trial to compare the efficacy of two different dosages of lymphoblastoid interferon alpha (IFN) for the treatment of chronic hepatitis C. Methods: Eighty-four patients...
3.
Kato S, Arao M, Kuriki J, Tagaya T, Takiya S, Kato K, et al.
Nagoya J Med Sci
. 1994 Dec;
57(3-4):153-7.
PMID: 7898571
Although chronic hepatitis C is frequently complicated by iron overload, it remains unclear whether iron cytotoxicity is involved in the disease process. Five patients with chronic hepatitis C showed rapid...
4.
Takeshima H, Yagi A, Yano M, Sakamoto N, Kato S, Kuriki J, et al.
Nagoya J Med Sci
. 1993 Mar;
55(1-4):115-23.
PMID: 8247100
Liver biopsy specimens from 18 patients with primary biliary cirrhosis were examined histochemically and by energy-dispersive x-ray microanalysis. Using two indices, we classified hepatic copper accumulation into three stages based...
5.
Fukui K, Kakumu S, Murakami H, Kuriki J, Yoshioka K, Sakamoto N
Clin Exp Immunol
. 1984 Oct;
58(1):90-6.
PMID: 6236920
We measured Ia antigen bearing peripheral blood T cells, as an index of immunological stimulation, of patients with chronic active liver diseases (CALD) by the rosette assay method. We also...
6.
Murakami H, Kuriki J, Kakumu S, Fukui K, Sakamoto N
Hepatology
. 1984 Mar;
4(2):192-8.
PMID: 6200416
Hybrid cell lines which secreted antibodies to liver-specific membrane lipoprotein (LSP) were obtained by immunizing SMA and BALB/c mice with human LSP and fusing their splenocytes with the myeloma cell...
7.
Kakumu S, Murakami H, Kuriki J
Hepatogastroenterology
. 1983 Jun;
30(3):86-9.
PMID: 6604010
Peripheral blood B cell response to staphylococcus aureus (SpA) Cowan I was evaluated in 8 healthy subjects, 8 patients with liver cirrhosis (LC), and 2 patients with chronic active hepatitis...
8.
Kakumu S, Murakami H, Kuriki J
Clin Exp Immunol
. 1983 May;
52(2):430-6.
PMID: 6222856
(+)Cyanidanol-3, a substance belonging to the flavonoids group, has been used in acute viral hepatitis (AVH) and chronic active liver disease (CALD). Studies were undertaken to determine if (+)cyanidanol-3 could...
9.
Kuriki J, Murakami H, Kakumu S, Sakamoto N, Yokochi T, Nakashima I, et al.
Gastroenterology
. 1983 Mar;
84(3):596-603.
PMID: 6218007
Experimental autoimmune hepatitis could be produced in SMA mice by monthly injections of syngeneic liver homogenate or liver-specific lipoprotein together with the polysaccharide of Klebsiella pneumoniae 03:K1 as a powerful...
10.
Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases
Hotta R, Kuriki J, Kakumu S
Clin Exp Immunol
. 1981 Nov;
46(2):375-81.
PMID: 6461458
Suppressor T cell function is decreased in patients with chronic active liver diseases (CALD). To account for the alterations, we examined the effect of sera of patients with various liver...